You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Human Longevity had filed the suit in July, alleging the misappropriation of trade secrets by Craig Venter, who founded both the company and the institute.
The firm is seeking damages and various injunctions, citing 11 different counts of fraud, breach of contract, tortious interference, and unfair competition.
Agilent alleges that Twist CEO Emily Leproust and other employees stole trade secrets from it. A trial date has been set for Feb. 24, 2020.
The suit names additional defendants and includes additional details about the technology Illumina is accused of appropriating.
A comprehensive study of genomics malpractice lawsuits showed only a modest increase in recent years, but ASU’s Marchant wouldn't bet on it staying this way in the long term.
A UK woman sues a hospital for not telling her of her father's genetic testing results, the Guardian reports.
Science reports that the Salk Institute has settled the third of its three gender discrimination lawsuits.
The lawsuit comes a few days after a jury awarded Bio-Rad Laboratories $23.9 million in damages in a patent infringement suit against 10x Genomics.
A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.
The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.